Table of Content - Insomnia Market Research Report – Forecast to 2032 | MRFR

Insomnia Drug Market Segmentation

Insomnia Drug Formulation Outlook (USD Billion, 2019-2030)

Capsules

Tablet

Others

Insomnia Type Of Diseases Outlook (USD Billion, 2019-2030)

Poor Quality Of Sleep

Sleep Maintenance

Others

Insomnia Types Of Therapy Outlook (USD Billion, 2019-2030)

Pharmacological Therapy

Non-Pharmacological Therapy

Insomnia Regional Outlook (USD Billion, 2019-2030)

North America Outlook (USD Billion, 2019-2030)
- North America Insomnia by Drug Formulation
  - Capsules
  - Tablet
  - Others
- North America Insomnia by Type Of Diseases
  - Poor Quality Of Sleep
  - Sleep Maintenance
  - Others
- North America Insomnia by Types Of Therapy
  - Pharmacological Therapy
  - Non-Pharmacological Therapy
- US Outlook (USD Billion, 2019-2030)
- US Insomnia by Drug Formulation
  - Capsules
  - Tablet
  - Others
- US Insomnia by Type Of Diseases
  - Poor Quality Of Sleep
  - Sleep Maintenance
  - Others
- US Insomnia by Types Of Therapy
  - Pharmacological Therapy
  - Non-Pharmacological Therapy
- CANADA Outlook (USD Billion, 2019-2030)
- CANADA Insomnia by Drug Formulation
  - Capsules
  - Tablet
  - Others
- CANADA Insomnia by Type Of Diseases
  - Poor Quality Of Sleep
  - Sleep Maintenance
  - Others
- CANADA Insomnia by Types Of Therapy
  - Pharmacological Therapy
  - Non-Pharmacological Therapy

Europe Outlook (USD Billion, 2019-2030)
- Europe Insomnia by Drug Formulation
  - Capsules
  - Tablet
  - Others
- Europe Insomnia by Type Of Diseases
  - Poor Quality Of Sleep
  - Sleep Maintenance
  - Others
- Europe Insomnia by Types Of Therapy
  - Pharmacological Therapy
  - Non-Pharmacological Therapy
- Germany Outlook (USD Billion, 2019-2030)
- Germany Insomnia by Drug Formulation
  - Capsules
  - Tablet
  - Others
- Germany Insomnia by Type Of Diseases
  - Poor Quality Of Sleep
  - Sleep Maintenance
  - Others
- Germany Insomnia by Types Of Therapy
  - Pharmacological Therapy
  - Non-Pharmacological Therapy
- France Outlook (USD Billion, 2019-2030)
- France Insomnia by Drug Formulation
  - Capsules
  - Tablet
  - Others
- France Insomnia by Type Of Diseases
  - Poor Quality Of Sleep
  - Sleep Maintenance
  - Others
- France Insomnia by Types Of Therapy
  - Pharmacological Therapy
  - Non-Pharmacological Therapy
- UK Outlook (USD Billion, 2019-2030)
- UK Insomnia by Drug Formulation
  - Capsules
  - Tablet
  - Others
- UK Insomnia by Type Of Diseases
  - Poor Quality Of Sleep
  - Sleep Maintenance
  - Others
- UK Insomnia by Types Of Therapy
  - Pharmacological Therapy
  - Non-Pharmacological Therapy
- ITALY Outlook (USD Billion, 2019-2030)
- ITALY Insomnia by Drug Formulation
  - Capsules
  - Tablet
  - Others
- ITALY Insomnia by Type Of Diseases
  - Poor Quality Of Sleep
  - Sleep Maintenance
  - Others
- ITALY Insomnia by Types Of Therapy
  - Pharmacological Therapy
  - Non-Pharmacological Therapy

SPAINOutlook (USD Billion, 2019-2030)

Spain Insomnia by Drug Formulation
- Capsules
- Tablet
- Others

Spain Insomnia by Type Of Diseases
- Poor Quality Of Sleep
- Sleep Maintenance
- Others

Spain Insomnia by Types Of Therapy
- Pharmacological Therapy
- Non-Pharmacological Therapy

Rest Of Europe Outlook (USD Billion, 2019-2030)

Rest Of Europe Insomnia by Drug Formulation
- Capsules
- Tablet
- Others

REST OF EUROPE Insomnia by Type Of Diseases
- Poor Quality Of Sleep
- Sleep Maintenance
- Others

REST OF EUROPE Insomnia by Types Of Therapy
- Pharmacological Therapy
- Non-Pharmacological Therapy

Asia-Pacific Outlook (USD Billion, 2019-2030)
- Asia-Pacific Insomnia by Drug Formulation
  - Capsules
  - Tablet
  - Others
- Asia-Pacific Insomnia by Type Of Diseases
  - Poor Quality Of Sleep
  - Sleep Maintenance
  - Others
- Asia-Pacific Insomnia by Types Of Therapy
  - Pharmacological Therapy
  - Non-Pharmacological Therapy
- China Outlook (USD Billion, 2019-2030)
- China Insomnia by Drug Formulation
  - Capsules
  - Tablet
  - Others
- China Insomnia by Type Of Diseases
  - Poor Quality Of Sleep
  - Sleep Maintenance
  - Others
- China Insomnia by Types Of Therapy
  - Pharmacological Therapy
  - Non-Pharmacological Therapy
- Japan Outlook (USD Billion, 2019-2030)
- Japan Insomnia by Drug Formulation
  - Capsules
  - Tablet
  - Others
- Japan Insomnia by Type Of Diseases
  - Poor Quality Of Sleep
  - Sleep Maintenance
  - Others
- Japan Insomnia by Types Of Therapy
  - Pharmacological Therapy
  - Non-Pharmacological Therapy
- India Outlook (USD Billion, 2019-2030)
- India Insomnia by Drug Formulation
  - Capsules
  - Tablet
  - Others
- India Insomnia by Type Of Diseases
  - Poor Quality Of Sleep
  - Sleep Maintenance
  - Others
- India Insomnia by Types Of Therapy
  - Pharmacological Therapy
  - Non-Pharmacological Therapy
- Australia Outlook (USD Billion, 2019-2030)
- Australia Insomnia by Drug Formulation
  - Capsules
  - Tablet
  - Others
- Australia Insomnia by Type Of Diseases
  - Poor Quality Of Sleep
  - Sleep Maintenance
  - Others
- Australia Insomnia by Types Of Therapy
  - Pharmacological Therapy
  - Non-Pharmacological Therapy
- Rest of Asia-Pacific Outlook (USD Billion, 2019-2030)
- Rest of Asia-Pacific Insomnia by Drug Formulation
  - Capsules
  - Tablet
  - Others
- Rest of Asia-Pacific Insomnia by Type Of Diseases
  - Poor Quality Of Sleep
  - Sleep Maintenance
  - Others
- Rest of Asia-Pacific Insomnia by Types Of Therapy
  - Pharmacological Therapy
  - Non-Pharmacological Therapy

Rest of the World Outlook (USD Billion, 2019-2030)
- Rest of the World Insomnia by Drug Formulation
  - Capsules
  - Tablet
  - Others
- Rest of the World Insomnia by Type Of Diseases
  - Poor Quality Of Sleep
  - Sleep Maintenance
  - Others
- Rest of the World Insomnia by Types Of Therapy
  - Pharmacological Therapy
  - Non-Pharmacological Therapy

Middle East Outlook (USD Billion, 2019-2030)

Middle East Insomnia by Drug Formulation
- Capsules
- Tablet
- Others

Middle East Insomnia by Type Of Diseases
- Poor Quality Of Sleep
- Sleep Maintenance
- Others

Middle East Insomnia by Types Of Therapy
- Pharmacological Therapy
- Non-Pharmacological Therapy

Africa Outlook (USD Billion, 2019-2030)

Africa Insomnia by Drug Formulation
- Capsules
- Tablet
- Others

Africa Insomnia by Type Of Diseases
- Poor Quality Of Sleep
- Sleep Maintenance
- Others

Africa Insomnia by Types Of Therapy
- Pharmacological Therapy
- Non-Pharmacological Therapy

Latin America Outlook (USD Billion, 2019-2030)

Latin America Insomnia by Drug Formulation
- Capsules
- Tablet
- Others

Latin America Insomnia by Type Of Diseases
- Poor Quality Of Sleep
- Sleep Maintenance
- Others

Latin America Insomnia by Types Of Therapy
- Pharmacological Therapy
- Non-Pharmacological Therapy

Research Methodology on Europe Insomnia Market

1. Introduction

The purpose of this research methodology is to provide a comprehensive overview of the methodology that will be employed to carry out the research project titled “Europe Insomnia Market - Forecast to 2030”. As this research involves studying the various aspects of the insomnia market in the Europe region, a detailed and comprehensive methodology is followed in order to ensure that the best possible results are obtained from the study.

2. Research Questions

What are the factors driving the growth of the Europe insomnia market?

What are the challenges and opportunities encountered in the Europe insomnia market?

What are the trends witnessed in the Europe insomnia market?

What is the competitive landscape in the Europe insomnia market?

What is the current and future potential of the Europe insomnia market?

3. Research Philosophy

The research philosophy adopted for this study is based on the interpretive approach, which allows for the investigation of the dynamic and complex relationships between different actors present in this market. The interpretive approach is particularly suitable for this study, as it allows for an in-depth and contextualized understanding of the market and its dynamics.

4. Nature of the Study

The nature of this study is descriptive, as it seeks to generate an in-depth understanding of the Europe insomnia market and its various aspects. The research involves gathering and analyzing both qualitative and quantitative data to identify the factors that are driving the market and the trends that are impacting its progress.

5. Data Collection Method

The primary data collection methods that are used for this study are survey techniques and secondary data sources. The survey techniques involve conducting interviews with various stakeholders in the European insomnia market, such as industry experts, government officials, and healthcare professionals. The survey questionnaire is designed in such a way that it captures the relevant information about the participant’s knowledge of the market and its dynamics. Secondary data sources include published reports by research organizations, journals, and other publications.

6. Sampling Method

The sampling method adopted for this study is a non-probability convenience sampling technique. This technique is used to ensure the targeted population is adequately represented in the sample. In order to ensure the reliability and validity of the sample, care is taken to ensure that the participants for the survey are selected through a systematic process and that no bias or preference is shown towards any particular participant or group.

7. Data Analysis

The data collected through the survey and the secondary sources are analyzed using qualitative and quantitative methods. Qualitative methods such as content analysis and thematic analysis are employed to identify the major drivers of the market and the trends that are impacting the progress of the market. Quantitative methods such as descriptive statistics and correlation analysis are used to identify the strengths and weaknesses of the various stakeholders in the market.

8. Conclusion

This research methodology summarizes the various methods that are employed for the research project titled “Europe Insomnia Market - Forecast to 2030”. The interpretive research philosophy has been adopted for the study, and data collection methods include both survey techniques and secondary data sources. The data collected is analyzed using both qualitative and quantitative methods, and the major limitations of the study have been identified.

Leading companies partner with us for data-driven Insights

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

TABLE OF CONTENTS

1. INTRODUCTION

1.1 DEFINITION

1.2 SCOPE OF STUDY

1.2.1 RESEARCH OBJECTIVE

1.2.2 ASSUMPTIONS & LIMITATIONS

1.2.2.1 ASSUMPTIONS

1 .2.2.2 LIMITATIONS

1.3 MARKET STRUCTURE:

2 RESEARCH METHODOLOGY

2.1 RESEARCH PROCESS:

2.2 PRIMARY RESEARCH

2.3 SECONDARY RESEARCH:

3 MARKET DYNAMICS

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 MACROECONOMIC INDICATORS

4 MARKET FACTOR ANALYSIS

4.1 PORTERS FIVE FORCES MODEL

4.2 BARGAINING POWER OF SUPPLIERS

4.3 BARGAINING POWER OF BUYERS

4.4 THREAT OF NEW ENTRANTS

4.5 THREAT OF SUBSTITUTES

4.6 INTENSITY OF RIVALRY

5. EUROPE, THE MIDDLE EAST AND AFRICA INSOMNIA MARKET, BY TYPES OF THERAPY

5.1 PHARMACOLOGICAL THERAPY

5.1.1 BENZODIAZEPINES

5.1.2 NON-BENZODIAZEPINES

5.1.3 MELATONIN RECEPTOR AGONISTS

5.1.4 OTHER

5.2 NON PHARMACOLOGICAL THERAPY

5.2.1 RELAXATION THERAPY

5.2.2 COGNITIVE BEHAVIORAL THERAPY

5.2.3 SLEEP HYGIENE EDUCATION

5.2.4 STIMULUS CONTRO

5.2.5 PARADOXICAL INTENTION

5.2.6 OTHER

6. EUROPE, THE MIDDLE EAST AND AFRICA INSOMNIA MARKET, BY DRUG FORMULATION

6.1 CAPSULES

6.2 TABLET

6.3 OTHERS.

7. EUROPE, THE MIDDLE EAST AND AFRICA INSOMNIA MARKET, BY TYPE OF DISEASE

7.1 POOR QUALITY OF SLEEP

7.2 SLEEP MAINTENANCE

7.3 OTHER.

8. EUROPE, THE MIDDLE EAST AND AFRICA INSOMNIA MARKET, BY REGION

8.1 INTRODUCTION

8.2 EUROPE

8.2.1 WESTERN EUROPE

8.2.1.1 GERMANY

8.2.1.2 FRANCE

8.2.1.3 U.K.

8.2.1.4 ITALY

8.2.1.5 SPAIN

8.2.1.6 REST OF EUROPE

8.2.2 EASTERN EUROPE

8.3 MIDDLE EAST AND AFRICA

8.3.1 UNITED ARAB EMIRATES

8.3.2 SAUDI ARABIA

8.3.3 QATAR

8.3.4 OMAN

8.3.5 KUWAIT

8.3.6 REST OF MIDDLE EAST AND AFRICA

9. COMPETITIVE LANDSCAPE

9.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS

9.1.1 STRATEGIC PARTNERSHIP

9.1.2 MERGER & ACQUISITION

10 COMPANY PROFILE

10.1 PFIZER INC.

10.1.1 OVERVIEW

10.1.2 PRODUCT OVERVIEW

10.1.3 FINANCIALS

10.1.4 KEY DEVELOPMENTS

10.2 GLAXOSMITHKLINE PLC.

10.2.1 OVERVIEW

10.2.2 PRODUCT OVERVIEW

10.2.3 FINANCIALS

10.2.4 KEY DEVELOPMENTS

10.3 SANOFI

10.3.1 OVERVIEW

10.3.2 PRODUCT OVERVIEW

10.3.3 FINANCIALS

10.3.4 KEY DEVELOPMENT STRATEGY

10.3.5 KEY DEVELOPMENT

10.4 ASTELLAS

10.4.1 OVERVIEW

10.4.2 PRODUCT OVERVIEW

10.4.3 FINANCIALS

10.4.4 KEY DEVELOPMENTS

10.5 BIOCODEX S A

10.5.1 OVERVIEW

10.5.2 PRODUCT OVERVIEW

10.5.3 FINANCIALS

10.5.4 KEY DEVELOPMENTS

10.6 OTHERS

11 CONCLUSION

112.1 KEY FINDINGS

112.1.1 FROM CEO’S VIEWPOINT

112.1.2 UNMET NEEDS OF THE MARKET

112.2 KEY COMPANIES TO WATCH

112.3 PREDICTION OF INSOMNIA INDUSTRY

12 APPENDIX

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

FEATURES	LICENCE TYPE
FEATURES	Single User	Multiuser Licence	Enterprise User
Price	$ 4,950	$ 5,950	$ 7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout The Organization.
Free Customization
Direct access to the Analyst
Deliverable Format
Deliverable Format
Platform Access
Discount on Your Next Purchase	10%	15%	10%
Printable Versions

Certified Global Research Member

Key Questions Answered

Why Choose Market Research Future?

Leading companies partner with us for data-driven Insights

Tailored for You